Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity.

× No keyword cloud information.

12 in total

Review 1. Recent advances in vaccine adjuvants.

Authors: Manmohan Singh; Derek T O'Hagan
Journal: Pharm Res Date: 2002-06 Impact factor: 4.200

Review 2. Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.

Authors: C E Taylor
Journal: Infect Immun Date: 1995-09 Impact factor: 3.441

3. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine.

Authors: S Sasaki; K Hamajima; J Fukushima; A Ihata; N Ishii; I Gorai; F Hirahara; H Mohri; K Okuda
Journal: Infect Immun Date: 1998-02 Impact factor: 3.441

4. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.

Authors: S Sasaki; T Tsuji; K Hamajima; J Fukushima; N Ishii; T Kaneko; K Q Xin; H Mohri; I Aoki; T Okubo; K Nishioka; K Okuda
Journal: Infect Immun Date: 1997-09 Impact factor: 3.441

5. Monophosphoryl lipid A behaves as a T-cell-independent type 1 carrier for hapten-specific antibody responses in mice.

Authors: K R Myers; P Beining; M Betts; H Snippe; J Inman; B Golding
Journal: Infect Immun Date: 1995-01 Impact factor: 3.441

6. Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.

Authors: J E Domer; L G Human; G B Andersen; J A Rudbach; G L Asherson
Journal: Infect Immun Date: 1993-05 Impact factor: 3.441

Review 7. Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors: A G Johnson
Journal: Clin Microbiol Rev Date: 1994-07 Impact factor: 26.132

Review 8. Recent advances of vaccine adjuvants for infectious diseases.

Authors: Sujin Lee; Minh Trang Nguyen
Journal: Immune Netw Date: 2015-04-23 Impact factor: 6.303

9. Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.

Authors: Atefeh Razazan; Javad Behravan; Atefeh Arab; Nastaran Barati; Leila Arabi; Zahra Gholizadeh; Mahdi Hatamipour; Amin Reza Nikpoor; Amir Abbas Momtazi-Borojeni; Fatemeh Mosaffa; Mohamad Hosein Ghahremani; Mahmoud Reza Jaafari
Journal: PLoS One Date: 2017-10-18 Impact factor: 3.240

10. Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.

Authors: Yingying Xu; Pak-Wai Yuen; Jenny Ka-Wing Lam
Journal: Pharmaceutics Date: 2014-07-10 Impact factor: 6.321